Trypan Blue Capsular Landmark for Precise Anterior Capsulotomy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for cataract surgery lack a reliable and precise way to identify the preferred location of the anterior capsulotomy, which is crucial for optimal intraocular lens (IOL) placement and minimizing complications like posterior capsule opacification and IOL tilt/dislocation.

Innovation Solution

A Trypan Blue ophthalmic solution formulation of 0.25 to 0.45% concentration is applied to the anterior chamber, creating a visibly intense blue stained region (Trypan Blue Capsular landmark) that corresponds to the intersection of the visual axis and the anterior capsule, allowing for precise centering of the capsulotomy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional cataract surgery methods are used without specialized staining, then the surgical procedure can be performed, but the precision of anterior capsulotomy location identification is insufficient

Engineering Contradiction:
Improveanterior capsulotomy location identificationVSAvoidsurgical procedure complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

Trypan Blue ophthalmic solution serves as an intermediary staining agent that selectively binds to the anterior lens capsule, creating a visually distinct blue landmark that precisely marks the optimal capsulotomy location. This mediator enables accurate identification without requiring complex imaging devices or additional surgical instruments.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The Trypan Blue dye produces a vivid blue color change in the anterior lens capsule, creating a high-contrast visual landmark that is easily distinguishable from surrounding tissues. This color transformation provides precise location identification through simple visual observation under standard surgical illumination.

Inventive Principle:
Principle #32Color changes

2Illumination intensity

If Trypan Blue concentration is increased to improve staining intensity, then visualization improves, but cell toxicity increases

Engineering Contradiction:
Improvestaining intensityVSAvoidcell toxicity
Core Design Contradiction:
Illumination intensityVSObject-affected harmful factors

Solution Approach 1:

The patent optimizes the Trypan Blue concentration parameter to a specific range (0.004% to 0.06%) that achieves sufficient staining intensity for clear visualization while remaining below the threshold for significant cell toxicity. This parameter optimization balances visual contrast with cellular safety.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The Trypan Blue stain creates a visual copy or replica of the anterior lens capsule boundary, producing a blue-colored landmark that replicates the capsule's location and shape. This visual copy provides accurate guidance for capsulotomy without requiring direct manipulation or intense staining that would harm cells.

Inventive Principle:
Principle #26Copying

3Manufacturing precision

If manual capsulotomy centering is performed without visual landmarks, then the surgery can proceed, but IOL placement precision is reduced

Engineering Contradiction:
ImproveIOL placement precisionVSAvoidsurgical time
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The Trypan Blue staining is applied preliminarily before the capsulotomy procedure, allowing the blue landmark to be established and visualized in advance. This preliminary action provides a pre-established visual reference that guides subsequent precise centering and capsulotomy execution, improving IOL placement accuracy without extending surgical time.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method provides a reliable, patient-independent, and tilt-independent visualization of the anterior capsulotomy location, enhancing the precision of IOL placement and reducing surgical complications by ensuring symmetric 360-degree coverage, thus improving surgical outcomes.

Implementation Method 1

Trypan Blue with a concentration of equal or less than 0.06% by weight has demonstrated significant affinity properties for the anterior lens capsule and showed an ability to improve visualization by color staining

Methodology Applied
Scientific EffectSelective binding: Adsorption

Implementation Method 2

Trypan Blue belongs to the anionic diazo family of vital dyes with the chemical formula C34H24N6Na4O14S4 and a molecular weight of 960. This organic compound is blue in appearance because red and orange light are strongly absorbed. Trypan Blue dissolved in a neutral pH aqueous solution has its maximum absorption in the orange region of the spectrum at about 590 nm.

Methodology Applied
Scientific EffectLight absorption: Absorption (EM radiation)

Data Source

PatentUS20220362410A1Preferred anterior capsulotomy location provided by trypan blue opthalmic solution
Publication Date: 2022.11.17 EXCEL LENS INC
  • US20220362410A1 patent drawing
  • US20220362410A1 patent drawing
  • US20220362410A1 patent drawing

AI summary

Trypan Blue ophthalmic solutions are used to create and identify a landmark on the anterior capsule of an eye and thus identify a preferred location for an anterior capsulotomy during cataract surgery.